Ivan Dimov is the co-founder and CEO of Orca Bio, a company dedicated to developing next-generation cell therapies. With a background in molecular diagnostics and stem cell research, Dimov has been instrumental in leading Orca Bio's vision to improve survival rates and reduce risks associated with traditional transplant processes. His innovative approach and leadership have positioned Orca Bio at the forefront of high-precision cell therapy development.
Who is the CEO of Orca Bio?
With a rich background in molecular diagnostics and stem cell research, Ivan Dimov has carved a niche for himself in the biotech industry. He co-founded Orca Bio in 2016, where he currently serves as CEO, driving the company's mission to develop high-precision cell therapies. Before Orca Bio, Dimov was the Chief Technology Officer at Lucira Health, known for its FDA-authorized COVID-19 at-home test.
Dimov's diverse experience and innovative mindset have been pivotal in advancing Orca Bio's groundbreaking work in cell therapy.
Work History
Ivan Dimov's extensive work history showcases his diverse experience and leadership in various roles across multiple organizations. Here is a detailed list of his professional journey:
- Orca Bio - Co-Founder and CEO (2018 to Present)
- Orca Bio - Co-Founder, CEO and CTO (2016 to 2018)
- Lucira Health - Co-Founder (2014 to 2023)
- Lucira Health - Co-founder, Board Member and CTO (2012 to 2014)
- Stanford University - Visiting Instructor and Senior Scientist (2010 to 2016)
- Blobcode Technologies Ltda. - Co-founder and CTO (2007 to 2014)
- UC Berkeley - Postdoctoral Associate (2009 to 2012)
- Universidad de Valparaíso - Associate Professor (2005 to 2012)
- Biomedical Diagnostics Institute - PhD Researcher (2007 to 2009)
- Chilean Hospital Technology Center (CTH) - Co-founder and Director (2005 to 2006)
- Instituto de Innovación en Minería y Metalurgia, CODELCO Chile - Mechatronics Sensor Researcher (2004 to 2005)
- INRIA - Researcher (2004)
- Bioautomatizacion - Co-founder (2004)
- Centro de Robotica, UTFSM - Co-founder (2001 to 2003)
Education History
Ivan Dimov's educational journey is marked by a series of impressive academic achievements. He earned his PhD in Applied Biophysics from Dublin City University, completing his studies in 2009. Prior to that, Dimov obtained a Master's of Science degree in Telecommunications and Computer Systems from Universidad Tecnica Federico Santa Maria, where he studied from 2003 to 2004. He also holds a Bachelor of Engineering in Civil Electronics from the same university, a degree he pursued from 1999 to 2004. Dimov's foundational education was completed at St Paul's College, where he achieved his IGCSE from the University of Cambridge between 1993 and 1998.
When did Ivan Dimov join Orca Bio?
Ivan Dimov co-founded Orca Bio in August 2016, where he initially served as CEO and CTO. By February 2018, he transitioned to the role of CEO, a position he continues to hold. This means Dimov has been with Orca Bio for over seven years, driving the company's mission to develop high-precision cell therapies. His leadership has been instrumental in positioning Orca Bio at the forefront of innovative cell therapy research and development.